DOI QR코드

DOI QR Code

Clinical and Genetic Features of Korean Inherited Arrhythmia Probands

  • Joo Hee Jeong (Division of Cardiology, Korea University College of Medicine and Korea University Medical Center) ;
  • Suk-Kyu Oh (Division of Cardiology, Korea University College of Medicine and Korea University Medical Center) ;
  • Yun Gi Kim (Division of Cardiology, Korea University College of Medicine and Korea University Medical Center) ;
  • Yun Young Choi (Division of Cardiology, Korea University College of Medicine and Korea University Medical Center) ;
  • Hyoung Seok Lee (Division of Cardiology, Korea University College of Medicine and Korea University Medical Center) ;
  • Jaemin Shim (Division of Cardiology, Korea University College of Medicine and Korea University Medical Center) ;
  • Yae Min Park (Department of Internal Medicine, Gachon University Gil Medical Center, Gachon University College of Medicine) ;
  • Jun-Hyung Kim (Department of Internal Medicine, Chungnam National University Hospital, Chungnam National University College of Medicine) ;
  • Yong-Seog Oh (Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea) ;
  • Nam-Ho Kim (Department of Internal Medicine, Wonkwang University Hospital, Wonkwang University School of Medicine) ;
  • Hui-Nam Pak (Department of Internal Medicine, Severance Cardiovascular Hospital, Yonsei University College of Medicine) ;
  • Young Keun On (Department of Internal Medicine, Heart Vascular and Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Hyung Wook Park (Department of Cardiology, Chonnam National University Hospital, Chonnam National University School of Medicine) ;
  • Gyo-Seung Hwang (Department of Cardiology, Ajou University School of Medicine) ;
  • Dae-Kyeong Kim (Department of Internal Medicine, Busan Paik Hospital, Inje University College of Medicine) ;
  • Young-Ah Park (Department of Internal Medicine, Busan Paik Hospital, Inje University College of Medicine) ;
  • Hyoung-Seob Park (Department of Internal Medicine, Keimyung University Dongsan Medical Center, Keimyung University College of Medicine) ;
  • Yongkeun Cho (Department of Internal Medicine, Kyungpook National University Hospital) ;
  • Seil Oh (Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine) ;
  • Jong-Il Choi (Division of Cardiology, Korea University College of Medicine and Korea University Medical Center) ;
  • Young-Hoon Kim (Division of Cardiology, Korea University College of Medicine and Korea University Medical Center)
  • Received : 2023.03.17
  • Accepted : 2023.06.13
  • Published : 2023.10.01

Abstract

Background and Objectives: Inherited arrhythmia (IA) is a more common cause of sudden cardiac death in Asian population, but little is known about the genetic background of Asian IA probands. We aimed to investigate the clinical characteristics and analyze the genetic underpinnings of IA in a Korean cohort. Methods: This study was conducted in a multicenter cohort of the Korean IA Registry from 2014 to 2017. Genetic testing was performed using a next-generation sequencing panel including 174 causative genes of cardiovascular disease. Results: Among the 265 IA probands, idiopathic ventricular fibrillation (IVF) and Brugada Syndrome (BrS) was the most prevalent diseases (96 and 95 cases respectively), followed by long QT syndrome (LQTS, n=54). Two-hundred-sixteen probands underwent genetic testing, and 69 probands (31.9%) were detected with genetic variant, with yield of pathogenic or likely pathogenic variant as 6.4%. Left ventricular ejection fraction was significantly lower in genotype positive probands (54.7±11.3 vs. 59.3±9.2%, p=0.005). IVF probands showed highest yield of positive genotype (54.0%), followed by LQTS (23.8%), and BrS (19.5%). Conclusions: There were significant differences in clinical characteristics and genetic yields among BrS, LQTS, and IVF. Genetic testing did not provide better yield for BrS and LQTS. On the other hand, in IVF, genetic testing using multiple gene panel might enable the molecular diagnosis of concealed genotype, which may alter future clinical diagnosis and management strategies.

Keywords

Acknowledgement

We thank all investigators of the Korean Inherited Arrhythmia Registry Network for their contribution to the pivotal basis for inherited arrhythmia research in Korea. We also thank Green Cross Genome (Y.E. Kim, E.H. Cho, J.M. Choi) for their support in genetic analysis.

References

  1. Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2018;72:1677-749.
  2. Roh SY, Choi JI, Park SH, et al. The 10-year trend of out-of-hospital cardiac arrests: a Korean nationwide population-based study. Korean Circ J 2021;51:866-74.
  3. Roh SY, Choi JI, Kim MS, et al. Incidence and etiology of sudden cardiac arrest in Koreans: A cohort from the national health insurance service database. PLoS One 2020;15:e0242799.
  4. Roh SY, Choi JI, Kim MS, et al. Trends in the use of implantable cardioverter-defibrillators for prevention of sudden cardiac arrest: a South Korean nationwide population-based study. Pacing Clin Electrophysiol 2019;42:1086-94.
  5. Murakoshi N, Aonuma K. Epidemiology of arrhythmias and sudden cardiac death in Asia. Circ J 2013;77:2419-31.
  6. Kim YG, Oh SK, Choi HY, Choi JI. Inherited arrhythmia syndrome predisposing to sudden cardiac death. Korean J Intern Med 2021;36:527-38.
  7. Priori SG, Wilde AA, Horie M, et al. HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. Heart Rhythm 2013;10:1932-63.
  8. Oliver GR, Hart SN, Klee EW. Bioinformatics for clinical next generation sequencing. Clin Chem 2015;61:124-35.
  9. Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015;17:405-24.
  10. Musunuru K, Hershberger RE, Day SM, et al. Genetic testing for inherited cardiovascular diseases: a scientific statement from the American Heart Association. Circ Genom Precis Med 2020;13:e000067.
  11. Kalia SS, Adelman K, Bale SJ, et al. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics. Genet Med 2017;19:249-55.
  12. Isbister JC, Nowak N, Butters A, et al. "Concealed cardiomyopathy" as a cause of previously unexplained sudden cardiac arrest. Int J Cardiol 2021;324:96-101.
  13. Bagnall RD, Weintraub RG, Ingles J, et al. A prospective study of sudden cardiac death among children and young adults. N Engl J Med 2016;374:2441-52.
  14. Cirino AL, Harris S, Lakdawala NK, et al. Role of genetic testing in inherited cardiovascular disease: a review. JAMA Cardiol 2017;2:1153-60.
  15. Sturm AC, Hershberger RE. Genetic testing in cardiovascular medicine: current landscape and future horizons. Curr Opin Cardiol 2013;28:317-25.
  16. Hosseini SM, Kim R, Udupa S, et al. Reappraisal of reported genes for sudden arrhythmic death: evidence-based evaluation of gene validity for Brugada syndrome. Circulation 2018;138:1195-205.
  17. Ackerman MJ, Priori SG, Willems S, et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Heart Rhythm 2011;8:1308-39.
  18. Shimizu W. Clinical impact of genetic studies in lethal inherited cardiac arrhythmias. Circ J 2008;72:1926-36.
  19. Lee YS, Kwon BS, Kim GB, et al. Long QT syndrome: a Korean single center study. J Korean Med Sci 2013;28:1454-60.
  20. Ahn KJ, Song MK, Lee SY, et al. The outcome of long QT syndrome, a Korean single center study. korean circ j 2022;52:771-81.
  21. Adler A, Novelli V, Amin AS, et al. An international, multicentered, evidence-based reappraisal of genes reported to cause congenital long QT syndrome. Circulation 2020;141:418-28.
  22. Bains S, Neves R, Bos JM, Giudicessi JR, MacIntyre C, Ackerman MJ. Phenotypes of overdiagnosed long QT syndrome. J Am Coll Cardiol 2023;81:477-86.
  23. Neves R, Tester DJ, Simpson MA, Behr ER, Ackerman MJ, Giudicessi JR. Exome sequencing highlights a potential role for concealed cardiomyopathies in youthful sudden cardiac death. Circ Genom Precis Med 2022;15:e003497.
  24. Grondin S, Davies B, Cadrin-Tourigny J, et al. Importance of genetic testing in unexplained cardiac arrest. Eur Heart J 2022;43:3071-81.
  25. Kim KH, Pereira NL. Genetics of cardiomyopathy: clinical and mechanistic implications for heart failure. Korean Circ J 2021;51:797-836.
  26. Lee HJ, Kim J, Chang SA, Kim YJ, Kim HK, Lee SC. Major clinical issues in hypertrophic cardiomyopathy. Korean Circ J 2022;52:563-75.